Curis
CRIS
#10209
Rank
HK$0.11 B
Marketcap
HK$8.67
Share price
-2.63%
Change (1 day)
-64.01%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.68. In 2024 the company made an earnings per share (EPS) of -HK$54.94 an increase over its 2023 EPS that were of -HK$70.57.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-47.98%
2024-HK$54.94-22.15%
2023-HK$70.57-26.17%
2022-HK$95.5722.3%
2021-HK$78.15-25.37%
2020-HK$104.72-30.93%
2019-HK$151.60-2.02%
2018-HK$154.73
2016-HK$351.66-10%
2015-HK$390.73138.1%
2014-HK$164.1140%
2013-HK$117.22-25%
2012-HK$156.2966.67%
2011-HK$93.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.63-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.21-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.81-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$18.60-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.41-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$87.84 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.02-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA